Patents by Inventor Thomas B. Shea

Thomas B. Shea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
    Patent number: 8597640
    Abstract: The present invention provides methods for improving cognitive function, improving mood, and decreasing aggression in a normal adult subject, and in a subject having symptoms characteristic of a neurological disorder, by administration of a nutriceutical formulation of the invention to the subject. The invention additionally features methods of treating neurological disorders, depression, and aggression using nutriceutical formulations. Nutriceutical compositions and formulations for use in the methods of the invention, and kits containing nutriceutical compositions and formulations, are also provided.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: December 3, 2013
    Assignee: University of Massachusetts Lowell
    Inventors: Thomas B. Shea, Amy Y. Chan-Daniels
  • FORMULATIONS FOR REDUCING NEURONAL DEGENERATION
    Publication number: 20120252750
    Abstract: Nutriceutical and pharmaceutical formulations for treating neurodegenerative disorders such as Alzheimer's disease are provided. Nutriceutical formulations include two or more of folate, vitamin E, and acetyl-L-carnitine (ALCAR). Pharmaceutical formulations include two or more of 3-deaza-adenosine (DZA), N-acetyl-L-cysteine (NAC), and S-adenosylmethionine (SAM).
    Type: Application
    Filed: April 2, 2012
    Publication date: October 4, 2012
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Thomas B. SHEA, Robert J. NICOLOSI, Eugene ROGERS
  • Formulations for reducing neuronal degeneration
    Patent number: 8173618
    Abstract: Nutriceutical and pharmaceutical formulations for treating neurodegenerative disorders such as Alzheimer's disease are provided. Nutriceutical formulations include two or more of folate, vitamin E, and acetyl-L-carnitine (ALCAR). Pharmaceutical formulations include two or more of 3-deaza-adenosine (DZA), N-acetyl-L-cysteine (NAC), and S-adenosylmethionine (SAM).
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: May 8, 2012
    Assignee: University of Massachusetts
    Inventors: Thomas B. Shea, Robert J. Nicolosi, Eugene Rogers
  • Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
    Publication number: 20090110745
    Abstract: The present invention provides methods for improving cognitive function, improving mood, and decreasing aggression in a normal adult subject, and in a subject having symptoms characteristic of a neurological disorder, by administration of a nutriceutical formulation of the invention to the subject. The invention additionally features methods of treating neurological disorders, depression, and aggression using nutriceutical formulations. Nutriceutical compositions and formulations for use in the methods of the invention, and kits containing nutriceutical compositions and formulations, are also provided.
    Type: Application
    Filed: April 4, 2008
    Publication date: April 30, 2009
    Applicant: UNIVERSITY OF MASSACHUSETTS LOWELL
    Inventors: Thomas B. Shea, Amy Y. Chan-Daniels